Approval of Low-blood Pressure Drug may be Cancelled by the FDA

Aug 17, 10 Approval of Low-blood Pressure Drug may be Cancelled by the FDA

Share Midodrine hydrochloride, the low blood pressure medicine, must be taken off the United State market for the reason that it required post-approval researches to confirm the medical advantage of the drug have not been completed, says the Food and Drug Administration. The medicine, promoted under the brand name ProAmatine by...

read more

Approval of Avastin may be Cancelled for Advanced Breast Cancer

Aug 16, 10 Approval of Avastin may be Cancelled for Advanced Breast Cancer

Share The United States Food and Drug Administration may be gaming with the impression of getting the very uncommon step of withdrawing endorsement of a medicine that patients with higher breast cancer revolve to as a final expectation. This medicine, Avastin, has been recommended to around 17,500 women experiencing from breast...

read more

US Markets will Soon be Trending a Better and More Effective Contraceptive Pill

Aug 15, 10 US Markets will Soon be Trending a Better and More Effective Contraceptive Pill

Share A latest contraceptive is put to strike the US market after the Food and Drug Administration (FDA) said it had specified its stick of endorsement to an ‘emergency pill’ that might be in use up to five days behind having defenseless sex. The contraceptive named Ella was approved after performing the concluding...

read more